Enzalutamide Clinical Trials
Here is the most popular medical study for enzalutamide
Popular filter options for enzalutamide trials
Clinical Trials With No Placebo
View 8 medical studies that do not have a placebo group.
Procedure
NUV-868 + Olaparib/Enzalutamide for Cancer
Recruiting1 awardPhase 1 & 2
Huntersville, North Carolina
This trial is testing a new drug, NUV-868, for safety and efficacy in patients with advanced solid tumors. The drug will be taken orally, either as a monotherapy or in combination with other drugs olaparib or enzalutamide, in 28-day cycles. The trial will continue until the disease progresses, there are unacceptable side effects, the patient withdraws consent, or the trial is terminated.
Procedure
PF-07220060 for Solid Cancers
Recruiting1 awardPhase 1 & 2
New Haven, Connecticut
This trial is testing a new drug, PF-07220060, to see if it is safe and effective when used alone or in combination with other drugs. The trial will be conducted in four parts, with escalating doses in the first part to determine the maximum tolerated dose (MTD) and recommended phase 2 dose (RP2D). The second part of the trial will test the drug in combination with two different endocrine therapies (letrozole and fulvestrant). The third part of the trial will assess the food effect of the RP2D dose from Part 1A. The fourth part of the trial will be an expansion for combination
Antiandrogen
HC-1119 vs Enzalutamide for Advanced Prostate Cancer
Recruiting2 awardsPhase 3
Washington, District of Columbia
This trial is a study to compare the effectiveness and safety of a new oral medication, HC-1119, to a current standard of care medication, enzalutamide, in men with asymptomatic or mildly symptomatic prostate cancer that has progressed despite treatment with prior hormone therapy.
Antiandrogen
Enzalutamide + ADT for Metastatic Prostate Cancer
Recruiting3 awardsPhase 3
Boston, Massachusetts
This trial is testing whether a new drug, enzalutamide, is more effective than a conventional non-steroidal anti androgen (NSAA), when combined with a luteinizing hormone releasing hormone analog (LHRHA) or surgical castration, as first line androgen deprivation therapy (ADT) for newly diagnosed metastatic prostate cancer.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.